Benchmark Research

San Francisco, California 94108

0 studies enrolling now · 12 studies all time

What they study most

Chlamydia Infections, Gonorrhea, Healthy Volunteers, Healthy or Stable Underlying Chronic Medical Condition, Hot Flashes, Influenza, Keratoconjunctivitis Sicca, Meningitis, Meningococcal, PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE, Plague Vaccine

Studies at this site

• Study of Rebamipide Eye Drops to Treat Dry Eye — Completed
• Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age — Completed
• Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant — Completed
• A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age — Completed
• Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. — Completed
• A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years — Completed
• Prospective Collection of Female and Male Specimens for PANTHER® System Testing — Completed
• Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms — Completed
• A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age — Completed
• Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers — Completed
• A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age — Completed
• Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o. — Status unconfirmed